Back to search

Article

First-in-human case report: AAV9-hGAA gene therapy for a patient with infantile-onset Pompe disease

2022-12-26

Abstract excerpt

<h4>Background</h4> The classic infantile-onset Pompe disease (IOPD) is characterized by cardiac hypertrophy, respiratory insufficiency, and rapidly progressive muscle weakness due to the acid alpha-glucosidase (GAA) deficiency. Enzyme replacement therapy (ERT) is the current approach for IOPD, but it entails several limitations. Aiming to overcome the limited efficiency of ERT, we developed adeno-associated virus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
429b80ca-d72b-5681-ad65-f00bd13dced3
DOI
10.1101/2022.12.22.22283398
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
First-in-human case report: AAV9-hGAA gene therapy for a patient with infantile-onset Pompe diseaseDOI 10.1101/2022.12.22.22283398
Select a neighboring publication to make it the new centre.